Work

Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study

Year: 2012

Type: article

Study design: Observational Study

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(12)70372-8

Authors: David Olmos, Daniel Brewer, Jeremy Clark, Daniel C Danila, Chris Parker, Gerhardt Attard, Martin Fleisher, Alison HM Reid, Elena Castro, Shahneen K Sandhu, Lorraine Barwell, Nikhil Babu Oommen, Suzanne Carreira, Charles G Drake, Robert Jones, Colin S Cooper, Howard I Scher, Johann S de Bono

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Spanish National Cancer Research Centre, Weill Cornell Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, Beatson West of Scotland Cancer Centre, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, University of Glasgow

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Prostate Cancer Foundation, Commonwealth Foundation for Cancer Research Foundation, Cancer Research UK, National Institute for Health and Care Research, Sociedad Española de Oncología Médica, European Regional Development Fund, National Cancer Institute

Awards: G2519382346, G4874885190, Regional Oncology Research Center

OpenAlex ID: W2153641732

FWCI: 12.87

Cites: 39

Cited by: 112

Related to: 10